ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01849874
Recruitment Status : Active, not recruiting
First Posted : May 9, 2013
Last Update Posted : October 19, 2018
Sponsor:
Information provided by (Responsible Party):
Array BioPharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : April 1, 2016
  Estimated Study Completion Date : September 2019
  Certification/Extension First Submitted : April 3, 2017